| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Nuclear receptor subfamily 2 group C member 2 |
|---|
| Ligand | BDBM375299 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | Inhibition Assay |
|---|
| IC50 | 117±n/a nM |
|---|
| Citation |  Treon, SP; Buhrlage, SJ; Gray, NS; Tan, L; Yang, G Methods to treat lymphoplasmacytic lymphoma US Patent US9908872 Publication Date 3/6/2018 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Nuclear receptor subfamily 2 group C member 2 |
|---|
| Name: | Nuclear receptor subfamily 2 group C member 2 |
|---|
| Synonyms: | NR2C2 | NR2C2_HUMAN | Nuclear receptor subfamily 2 group C member 2 | Nuclear receptor subfamily 2 group C member 2 (TAK1) | TAK1 | TR4 |
|---|
| Type: | PROTEIN |
|---|
| Mol. Mass.: | 65411.75 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | ChEMBL_1476357 |
|---|
| Residue: | 596 |
|---|
| Sequence: | MTSPSPRIQIISTDSAVASPQRIQIVTDQQTGQKIQIVTAVDASGSPKQQFILTSPDGAG
TGKVILASPETSSAKQLIFTTSDNLVPGRIQIVTDSASVERLLGKTDVQRPQVVEYCVVC
GDKASGRHYGAVSCEGCKGFFKRSVRKNLTYSCRSNQDCIINKHHRNRCQFCRLKKCLEM
GMKMESVQSERKPFDVQREKPSNCAASTEKIYIRKDLRSPLIATPTFVADKDGARQTGLL
DPGMLVNIQQPLIREDGTVLLATDSKAETSQGALGTLANVVTSLANLSESLNNGDTSEIQ
PEDQSASEITRAFDTLAKALNTTDSSSSPSLADGIDTSGGGSIHVISRDQSTPIIEVEGP
LLSDTHVTFKLTMPSPMPEYLNVHYICESASRLLFLSMHWARSIPAFQALGQDCNTSLVR
ACWNELFTLGLAQCAQVMSLSTILAAIVNHLQNSIQEDKLSGDRIKQVMEHIWKLQEFCN
SMAKLDIDGYEYAYLKAIVLFSPDHPGLTSTSQIEKFQEKAQMELQDYVQKTYSEDTYRL
ARILVRLPALRLMSSNITEELFFTGLIGNVSIDSIIPYILKMETAEYNGQITGASL
|
|
|
|---|
| BDBM375299 |
|---|
| n/a |
|---|
| Name | BDBM375299 |
|---|
| Synonyms: | US10597387, Compound (I-5) | US9908872, Compound (I-5) |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C31H30F3N5O2S |
|---|
| Mol. Mass. | 593.662 |
|---|
| SMILES | CCN1CCN(CC1)c1ccc(NC(=O)c2ccc(C)c(NC(=O)c3cncc(c3)-c3cccs3)c2)cc1C(F)(F)F |
|---|
| Structure | 
|
|---|
Search and Browse
